Zacks: Brokerages Anticipate Nu Skin Enterprises, Inc. (NYSE:NUS) Will Announce Quarterly Sales of $725.58 Million

Equities research analysts expect Nu Skin Enterprises, Inc. (NYSE:NUS) to announce sales of $725.58 million for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Nu Skin Enterprises’ earnings, with the lowest sales estimate coming in at $725.10 million and the highest estimate coming in at $726.06 million. Nu Skin Enterprises reported sales of $703.35 million during the same quarter last year, which indicates a positive year over year growth rate of 3.2%. The firm is scheduled to report its next quarterly earnings results on Wednesday, November 3rd.

On average, analysts expect that Nu Skin Enterprises will report full year sales of $2.84 billion for the current year, with estimates ranging from $2.83 billion to $2.86 billion. For the next year, analysts forecast that the firm will post sales of $2.97 billion, with estimates ranging from $2.95 billion to $2.99 billion. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that that provide coverage for Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, August 4th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.06 by $0.09. Nu Skin Enterprises had a net margin of 8.35% and a return on equity of 26.95%. The company had revenue of $704.10 million during the quarter, compared to analysts’ expectations of $703.38 million. During the same period last year, the business earned $0.81 EPS. Nu Skin Enterprises’s revenue for the quarter was up 15.0% on a year-over-year basis.

Separately, Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating and set a $57.00 price target on the stock. in a research report on Monday, August 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $60.60.

NYSE NUS traded down $0.73 on Thursday, hitting $41.69. The company had a trading volume of 25,863 shares, compared to its average volume of 500,864. The company has a market capitalization of $2.09 billion, a PE ratio of 9.16 and a beta of 1.15. The company’s fifty day moving average price is $51.30 and its 200-day moving average price is $54.34. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.56 and a quick ratio of 0.93. Nu Skin Enterprises has a 12-month low of $41.25 and a 12-month high of $63.85.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 8th. Shareholders of record on Friday, August 27th were paid a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 3.65%. The ex-dividend date was Thursday, August 26th. Nu Skin Enterprises’s payout ratio is 41.87%.

In other news, General Counsel D Matthew Dorny sold 6,200 shares of the business’s stock in a transaction on Friday, July 2nd. The stock was sold at an average price of $56.88, for a total transaction of $352,656.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Joseph Y. Chang sold 16,000 shares of the company’s stock in a transaction on Monday, September 13th. The shares were sold at an average price of $47.41, for a total value of $758,560.00. Following the transaction, the executive vice president now directly owns 33,942 shares in the company, valued at $1,609,190.22. The disclosure for this sale can be found here. Insiders own 4.00% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Royal Bank of Canada boosted its stake in shares of Nu Skin Enterprises by 157.0% during the 1st quarter. Royal Bank of Canada now owns 36,074 shares of the company’s stock worth $1,907,000 after acquiring an additional 22,038 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Nu Skin Enterprises by 39.6% in the 1st quarter. Victory Capital Management Inc. now owns 110,271 shares of the company’s stock valued at $5,832,000 after acquiring an additional 31,253 shares in the last quarter. Blueshift Asset Management LLC raised its holdings in Nu Skin Enterprises by 73.4% in the 1st quarter. Blueshift Asset Management LLC now owns 12,125 shares of the company’s stock valued at $641,000 after acquiring an additional 5,133 shares in the last quarter. Teacher Retirement System of Texas raised its holdings in Nu Skin Enterprises by 21.0% in the 1st quarter. Teacher Retirement System of Texas now owns 5,935 shares of the company’s stock valued at $314,000 after acquiring an additional 1,031 shares in the last quarter. Finally, Financial Enhancement Group LLC acquired a new position in Nu Skin Enterprises in the 1st quarter valued at approximately $1,795,000. 81.06% of the stock is currently owned by institutional investors.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J.

See Also: What is a short straddle?

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.